Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- USD | -.--% | -6.22% | +78.50% |
2018 | Transcript : Argos Therapeutics, Inc. - Special Call | |
2017 | Transcript : Argos Therapeutics, Inc., Q3 2017 Earnings Call, Nov 13, 2017 |
Kurzporträt
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 10 586 661 | 9 393 074 ( 88,73 %) | 0 | 88,73 % |
Unternehmenskontakt
Argos Therapeutics, Inc.
4233 Technology Drive
27704-2173, Durham
+919-287-6300
http://www.argostherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+78.50% | 566’915 | |
+0.82% | 91.94 Mrd. | |
-1.32% | 38.74 Mrd. | |
-12.88% | 32.82 Mrd. | |
+64.77% | 26.66 Mrd. | |
-16.31% | 15.32 Mrd. | |
-11.38% | 11.65 Mrd. | |
+173.10% | 10.37 Mrd. | |
-49.84% | 10.12 Mrd. | |
+5.24% | 9.06 Mrd. |
- Börse
- Aktien
- A2G8YQ Aktie
- Unternehmen Argos Therapeutics, Inc.